Summary
Down syndrome (DS) is a genetic disease that exhibits significant neuropathological parallels with Alzheimer’s disease (AD). One of the features of DS, neuronal loss, has been hypothesized to occur as a result of apoptosis. An increasing number of proteins are implicated in apoptosis and several of them were shown to be altered in AD, however, the knowledge in DS is far from complete. To further substantiate the hypothesis that apoptosis is the underlying mechanism for neuronal loss and contribute towards the current knowledge of apoptosis in DS, we analyzed the expression of apoptosis related proteins in frontal cortex and cerebellum of DS by western blot and ELISA techniques. Quantitative analysis revealed a significant increase in DS frontal (P < 0.0001) and cerebellar (P < 0.05) Bim/BOD (Bcl-2 interacting mediator of cell death/Bcl-2 related ovarian death gene), cerebellar Bcl-2 (P < 0.01) as well as p21 (P < 0.05) levels compared to controls. No significant change was detected in Bax, RAIDD (receptor interacting protein (RIP)-associated ICH-l/CED-3-homologus protein with death domain), ZIP (Zipper interacting protein) kinase and NF-kB p65 levels in both regions, although frontal cortex levels of RAIDD, Bcl-2 and p21 levels tended to increase. In addition, a 45 kDa truncated form of NF-kB p65 displayed a significant elevation (P < 0.05) in DS cerebellum. No significant correlation had been obtained between postmortem interval and level of the proteins analyzed. With regard to age, it was only NF-kB p65 that showed significant correlation (r = -0.8964, P = 0.0155, n = 9) in frontal cortex of controls. These findings provide further evidence that apoptosis indeed accounts for the neuronal loss in DS but Bax and RAIDD do not appear to take part in this process.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Ahmad M, Srinivasula SM, Wang L, Talanian RV, Litwack G, Fernandes-Alnemri T,Alnemri ES (1997) CRADD, a novel human apoptotic adaptor molecule for caspase-2, and FASL/tumor necrosis factor receptor interacting protein, RIP. Cancer Res 57: 615–619
Anderson AJ, Stoltzner S, Lai Florence Su J, Nixon RA (2000) Morphological and biochemical assessment of DNA damage and apoptosis in Down syndrome and Alzheimer’s disease, and effect of postmortem tissue archival on TUNEL. Neurobiol Aging 21: 511–524
Andersson P (1997) Kinase cascades regulating entry into apoptosis. Microbiol Mol Biol Rev 66: 33–46
Aravind L, Dixit VM, Koonin EV (1999) The domains of death: evolution of the apoptosis machinery. TIBS 24: 47–53
Asada M, Yamada T, Ichijo H, Delia D, Miyazono K, Fukumoro K, Mizutani S (1999)Apoptosis inhibitory activity of cytoplasmic p21 (Cipl/WaFl) in monocyte differentiation. EMBO J 18: 1223–1234
Castagne V, Gautschi M, Lefevre K, Posada A, Clarke PGH (1999) Relationships between neuronal death and the cellular redox status. Focus on the developing nervous system. Prog Neurobiol 59: 397–423
Chang BD, Watanabe K, Broude EV, Fang J, Poole JC, Kalinichenko TV, Roninson IB (2000) Effects of p21 (WAF-1, Cip-1, Sdi-1) on cellular gene expression: implication for carcinogenesis, senescence and age related disease. Proc Natl Acad Sci USA 94: 11357–11362
Chen J, Jackson PK, Kirschner MW, Duzta A (1995) Separate domains of p21 involved in the inhibition of CDK kinase and PCNA. Nature 374: 386–388
de Hann JB, Cristiano F, Iannello RC, Kola I (1995) Cu/Zn-superoxide dismutase and gluthatione peroxidase during aging. Biochem Mol Biol Int 35: 1281–1297
de la Monte SM, Sohn YK, Ganju YK, Wands JR (1998) p53 and CD95 associated apoptosis in neurodegenerative diseases. Lab Invest 78: 401–411
Deng G, Su JH, Ivins KJ, Van Houten B, Cotman CW (1999) Bcl-2 facilitates recovery from DANN damage after oxidative stress. Exp Neurol 159: 309–318
Duan H, Dixit VM (1997) RAIDD is a new death adaptor molecule. Nature 385: 86–89
El-Diery WS, Harper JW, O’Connor PM, Velculescu VE, Canman CE, Jackmann J, Pietenpol JA (1994) WAF1/CIP1 is induced in p53 mediated Gl arrest and apoptosis. Cancer Res 54: 1169–1174
Engidawork E, Gulesserian T, Seidl R, Cairns N, Lubec G (2001) Expression of apoptosis related proteins in brains of patients with Alzheimer’s disease. Neurosci Lett 303: 79–82
Franzoso G, Biswas P, Poli G, Carlson LM, Brown KD, Tomita-Yamaguchi M, Fauci AS, Siebelist UK (1994) A family of serine proteases expressed exclusively in myleo- monocytic cells specifically process the NF-KB subunit p65 in vitro and may impair HIV replication in these cells. J Exp Med 180: 1445–1456
Grilli M, Memo M (1999) Nuclear factor-kappa B/Rel proteins: a point of convergence of signaling pathways relevant in neuronal function and dysfunction. Biochem Pharmacol 57: 1–7
Gulesserian T, Engidawork E, Yoo BC, Cairns N, Lubec G (2001) Comparable apoptotic pathways in frontal cortex and cerebellum of patients with Down syndrome (this volume)
Hofmann K, Bucher P, Tschopp J (1997) The CARD domain: a new apoptotic signaling motif. Trends Biochem Sci 22: 155
Hsu SY, Lin P, Hsueh AJ BOD (Bcl-2 related ovarian death gene) is an ovarian BH3 domain containing proapoptotic Bcl-2 protein capable of dimerization with diverse antiapoptotic Bcl-2 members. Mol Endocrinol 12: 1432–1440
Kaltschmidt B, Uherek M, Volk B, Baeuerle PA, Kaltschmidt C (1997) Transcription factor NF-KB is activated in primary neurons by amyloid β peptides in neurons surrounding early plaques from patients with Alzheimer’s disease. Proc Natl Acad Sci USA 94: 2642–2647
Kaltschmidt B, Uherek M, Volk B, Wellmann H, Kaltschmidt C (1999) Inhibition of NF-KB potentiates amyloid ß peptide mediated neuronal apoptosis. Proc Natl Acad Sci USA 96: 9409–9414
Kawai T, Matsumoto M, Takeda K, Sanjo H, Akira S (1998) ZIP kinase, a novel serine/ threonine kinase which mediates apoptosis. Mol Cell Biol 18: 1642–1651
Kogel D, Bierbaum H, Preuss U, Scheidtmann KH (1999) C-terminal truncation of Dlk/ ZIP kinase leads to abrogation of nuclear transport and high apoptotic activity. Oncogene 18: 7212–7218
Krosmeyer SJ (1995) Regulators of cell death. Trends Genet 11: 101–105
Lowry OH, Rosebrough NJ, Farr AL, Randal RJ (1951) Protein measurement with the folin phenol reagent. J Biol Chem 193: 265–275
Mann DMA (1988) The pathological association between Down Syndrome and Alzheimer’s disease. Mech Aging Dev 43: 99–136
Mattson MP, Culmsee C, Yu Z, Camandola S (2000) Roles of nuclear factor kappa B in neuronal survival and plasticity. J Neurochem 74: 443–456
Mattson MP, Duan W, Chan SL, Camandola S (1999) Par-4: an emerging pivotal player in neuronal apoptosis and neurodegenerative disorders. J Mol Neurosci 13: 17–30
Moore PA, Ruben SM, Rosen CA (1993) Conservation of transcriptional activation functions of the NF-KB p50 and p65 subunits in mammalian cells and Sacchromyces cerevisiae. Mol Cell Biol 13: 1666–1674
Nagy ZS, Esiri MM (1997) Apoptosis related protein expression in the hippocampus in Alzheimer’s disease. Neurobiol Aging 18: 565–571
O’Connor L, Strasser A, O’Reilly LA, Hausmann G, Adams JM, Cory S, Huang DC (1998) Bim: a novel member of the Bcl-2 family that promotes apoptosis. EMBO J 17: 384–395
Oltvazi ZN, Milliman CL, Krosmeyer SJ (1993) Bcl-2 hetrodimerizes in vivo with a conserved homolog Bax that accelerates programmed cell death. Cell 74: 609–619
Page G, Kogel D, Rangnekar V, Scheidtmann KH (1999) Interaction partners of Dlk/ZIP kinase: co-expression of Dlk/ZIP kinase and Par-4 results in cytoplasmic retention and apoptosis. Oncogene 18: 7265–7273
Polyak K, Waldman T, He TC, Kinzler KW, Vogelstein B (1996) Genetic determinants of p53 induced apoptosis and growth arrest. Genes Dev 10: 1945–1952
Satou T, Cummings BJ, Cotman CW (1995) Immunoreactivity for Bcl-2 protein within neurons in the Alzheimer’s disease brain increases with disease severity. Brain Res 697: 35–43
Sawa A, Oyama F, Cairns NJ, Amano N, Matsushita M (1997) Aberrant expression of Bcl-2 gene family in Down syndrome brains. Mol Brain Res 48: 53–59
Seidl R, Fang-Kircher S, Bidmon B, Cairns N, Lubec G (1999) Apoptosis associated protein p53 and APO-1/Fas (CD95) in brains of adult patients with Down syndrome. Neurosci Lett 260: 9–12
Sherr CJ, Roberts JM (1995) Inhibitors of mammalian Gl cyclin dependent kinases. Genes Dev 9: 1149–1163
Shim J, Lee H, Park J, Kim H, Choi EJ (1996) A nonenzymatic p21 protein inhibitor of stress activated protein kinases. Nature 381: 804–806
Simeonidis S, Liang S, Chen G, Thanos D (1997) Cloning and functional characterization of mouse IKB epsilon. Proc Natl Acad Sci USA 94: 14372–14377
Steinman RA, Hoffman B, Iro A, Guillouf C, Liebermann DA, el-Houseini ME (1994) Induction of p21 (Waf-1/CIPl) during differentiation. Oncogene 9: 3389–3396
Tsujimoto Y, Cossman J, Jette E, Croce CM (1985) Involvement of the Bcl-2 gene in human follicular lymphoma. Science 228: 1440–1443
Verheij M, Bose R, Lin XH, Yao B, Jarvis WD, Grant S, Birrer MJ, Szabo E, Zon LI, Kyriakis JM, Haimovitz-Friedman A, Fuks Z, Kolesnick RN (1996) Requirement for ceramide initiated SAPK/JNK signaling in stress induced apoptosis. Nature 380: 75– 79
Villunger A, Huang DCS, Holler N, Tschopp J, Strasser A (2000) Fas ligand induced c- Jun kinase activation in lymphoid cells requires extensive receptor aggregation but is independent of DAXX, and Fas-mediated cell death does not involve DAXX, RIP or RAIDD. J Immunol 165: 1337–1343
Wolf BB, Green DR (1999) Suicidal tendencies: apoptotic cell death by caspase family proteinases. J Biol Chem 274: 20049–20052
Wu H, Wade M, Krall L, Grisham J, Xiong Y, Van Dyke T (1996) Targeted in vivo expression of the cyclin dependent kinase inhibitor p21 halts hepatocytes cell cycle progression, postnatal liver development and regeneration. Genes Dev 10: 245–260
Yoshioka K, Yamamoto S, Moriguchi N, Miyata H, Tsukiyama K, Isokawa S, Horiuchi F, Takemura T (2000) Overexpression of Bcl-2 in transient abnormal myleopoiesis associated with Down syndrome. Ann Hematol 79: 319–321
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer-Verlag/Wien
About this chapter
Cite this chapter
Engidawork, E., Gulesserian, T., Seidl, R., Cairns, N., Lubec, G. (2001). Expression of apoptosis related proteins: RAIDD, ZIP kinase, Bim/BOD, p21, Bax, Bcl-2 and NF-kB in brains of patients with Down syndrome. In: Lubec, G. (eds) Protein Expression in Down Syndrome Brain. Springer, Vienna. https://doi.org/10.1007/978-3-7091-6262-0_14
Download citation
DOI: https://doi.org/10.1007/978-3-7091-6262-0_14
Publisher Name: Springer, Vienna
Print ISBN: 978-3-211-83704-7
Online ISBN: 978-3-7091-6262-0
eBook Packages: Springer Book Archive